BASIS Optimization
University of Washington · with University of Kansas, National Institute of Mental Health (NIMH) · NCT06672835
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 32
- US sites recruiting
- 1
- Study start
- October 5, 2024
- Record last updated
- April 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of the BASIS R34 pilot study is to test the impact of eBASIS in a randomized controlled trial (RCT). Consistent with IMPACT's IQM, the study tests effects of eBASIS on treatment fidelity and youth outcomes, compared to a digitally delivered control (N=32 clinicians; 96 clients). A well-established EBP (Cognitive Behavioral Therapy Plus), will be a focus of the investigation, which eligible participants will already be signed up to receive.
Being studied: eBASIS; eAttention Control
Conditions: Mental Health; Health Services; Evidence Based Programs in Schools
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Mental health provider who spends 2 hours or more providing supports in school setting
- Registered to receive CBT+ training from the WA State EBP Initiative
Exclusion Criteria
- None
Recruiting US locations
University of Washington
Seattle, WA 98115
Site contact: Aaron Lyon, PhD · 206-221-8604 · lyona@uw.edu
Study contacts (from the official record)
- Aaron Lyon, PhD · 206-221-8604 · lyona@uw.edu
- Maria Hugh, PhD · 785-864-1143 · mariahugh@ku.edu
Similar studies in Washington
All mental health studies in Washington →- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Seattle, WA + 50 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With…
LivaNova
- Location
- Mercer Island, WA + 49 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Everett, WA + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
- Location
- Seattle, WA + 27 other US sites
- Eligibility basics
- Ages 18–85